Skip to main content
Have a personal or library account? Click to login
A Review of Acute Coronary Syndrome and its Potential Impact on Cognitive Function Cover

A Review of Acute Coronary Syndrome and its Potential Impact on Cognitive Function

Open Access
|Aug 2021

References

  1. Eurostat. Population structure and ageing. Eurostat Statistics Explained [online], https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing (accessed 2 December 2019).
  2. World Health Organization. International statistical classification of diseases and related health problems, 10th Revision. Geneva: World Health Organization; 1992.
  3. World Health Organization. The epidemiology and impact of dementia: current state and future trends. Geneva: World Health Organization; 2015, Document WHO/MSD/MER/15.3. http://www.who.int/mental_health/neurology/dementia/dementia_thematicbrief_epidemiology.pdf (accessed 2 December 2019).
  4. World Health Organization. The Global Dementia Observatory Reference Guide. Geneva, Switzerland: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/272669/WHO-MSD-MER-18.1-eng.pdf?ua=1 (accessed 2 December 2019).
  5. Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment: Report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018; 90(3): 126135. DOI: 10.1212/WNL.0000000000004826
  6. Fleisher AS, Sowell BB, Taylor C, et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2007; 68(19): 15881595. DOI: 10.1212/01.wnl.0000258542.58725.4c
  7. Ganguli M, Snitz BE, Saxton JA, et al. Outcomes of mild cognitive impairment depend on definition: A population study. Arch Neurol. 2011; 68(6): 761767. DOI: 10.1001/archneurol.2011.101
  8. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009; 119(4): 25265. DOI: 10.1111/j.1600-0447.2008.01326.x
  9. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005; 62(7): 11603. DOI: 10.1001/archneur.62.7.1160
  10. Petersen RJ. Mild Cognitive Impairment as a Useful Clinical Concept. Psychiatric Times. 2004; 21(1): 32.
  11. Molano J, Boeve B, Ferman T, et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: A clinicopathological study. Brain. 2010; 133(2): 540556. DOI: 10.1093/brain/awp280
  12. Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005; 64(5): 83441. DOI: 10.1212/01.WNL.0000152982.47274.9E
  13. Roberts OR, Knopman DS, Geda YE, et al. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging. 2010; 31(11): 1894902. DOI: 10.1016/j.neurobiolaging.2008.10.018
  14. Freiheit EA, Hogan DB, Eliasziw M, et al. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen Psychiatry. 2012; 69(3): 244255. DOI: 10.1001/archgenpsychiatry.2011.1361
  15. Sundbøll J, Horváth-Puhó E, Adelborg K, Schmidt M, et al. Higher Risk of Vascular Dementia in Myocardial Infarction Survivors. Circulation. 2018; 137(6): 567577. DOI: 10.1161/CIRCULATIONAHA.117.029127
  16. Gu Sophie Z, et al. Cognitive Decline in Older Patients With Non- ST Elevation Acute Coronary Syndrome. Journal of the American Heart Association. 2019; 8(4): e011218. DOI: 10.1161/JAHA.118.011218
  17. Bursi F, Rocca WA, Killian JM, et al. Heart disease and dementia: A population-based study. Am J Epidemiol. 2006; 163(2): 135141. DOI: 10.1093/aje/kwj025
  18. Petrovitch H, White L, Masaki KH, et al. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. Am J Cardiol. 1998; 81(8): 10171021. DOI: 10.1016/S0002-9149(98)00082-4
  19. Deckers K, Schievink SHJ, Rodriquez MMF, et al. Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis. PLoS One. 2017; 12(9). DOI: 10.1371/journal.pone.0184244
  20. Justin BNG, Turek M, Hakim AM. Heart disease as a risk factor for dementia. Clin Epidemiol. 2013; 5: 135145. DOI: 10.2147/CLEP.S30621
  21. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002; 58(8): 11751181. DOI: 10.1212/WNL.58.8.1175
  22. Jagust W. What can imaging reveal about obesity and the brain? Curr Alzheimer Res. 2007; 4(2): 135139. DOI: 10.2174/156720507780362146
  23. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001; 154(7): 635641. DOI: 10.1093/aje/154.7.635
  24. Mielke MM, Leoutsakos J-M, Tschanz JT. Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer’s disease. J Alzheimers Dis. 2011; 26(1) 127134. DOI: 10.3233/JAD-2011-110086
  25. Xie W, Zheng F, Yan L, et al. Cognitive Decline Before and After Incident Coronary Events. J Am Coll Cardiol. 2019; 73(24): 30413050. DOI: 10.1016/j.jacc.2019.04.019
  26. Volonghi I, Pendlebury ST, Welch SJ, et al. Cognitive outcomes after acute coronary syndrome: A population-based comparison with transient ischaemic attack and minor stroke. Heart. 2013; 99(20): 150914. DOI: 10.1136/heartjnl-2013-304207
  27. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 28197. DOI: 10.1016/S0092-8674(04)00045-5
  28. Cordes KR, Srivastava D, Ivey KN. MicroRNAs in cardiac development. Pediatr. Cardiol. 2010; 31(3): 349356. DOI: 10.1007/s00246-010-9639-3
  29. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids—The mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011; 8(9): 46777. DOI: 10.1038/nrclinonc.2011.76
  30. Allegra A, Alonci A, Campo S, et al. Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol. 2012; 41(6): 1897912. DOI: 10.3892/ijo.2012.1647
  31. Chen X, Liang H, Zhang J, et al. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 2012; 22(3): 12532. DOI: 10.1016/j.tcb.2011.12.001
  32. Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O, et al. MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther. 2014; 7: 132738. DOI: 10.2147/OTT.S61562
  33. Valadi H, Ekstrom K, Bossios A, et al. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 6549. DOI: 10.1038/ncb1596
  34. Ma JC, Duan MJ, Sun LL, et al. Cardiac over-expression of microRNA-1 induces impairment of cognition in mice. Neuroscience. 2015; 299: 6678. DOI: 10.1016/j.neuroscience.2015.04.061
  35. Duan MJ, Yan ML, Wang Q, et al. Overexpression of miR-1 in the heart attenuates hippocampal synaptic vesicle exocytosis by the posttranscriptional regulation of SNAP-25 through the transportation of exosomes. Cell Commun Signal. 2018; 16(1): 91. DOI: 10.1186/s12964-018-0303-5
  36. Jellinger KA, Attems J. Is there pure vascular dementia in old age? J Neurol Sci. 2010; 299(1–2): 1504. DOI: 10.1016/j.jns.2010.08.038
  37. McAleese KE, Alafuzoff I, Charidimou A. Post-mortem assessment in vascular dementia: Advances and aspirations. BMC Med. 2016; 14(1): 129. DOI: 10.1186/s12916-016-0676-5
  38. Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007; 257(1–2): 807. DOI: 10.1016/j.jns.2007.01.045
  39. Kovacs GG, Alafuzoff I, Al-Sarraj S, et al. Mixed brain pathologies in dementia: The BrainNet Europe consortium experience. Dement Geriatr Cogn Disord. 2008; 26(4): 34350. DOI: 10.1159/000161560
  40. Larsson SC, Markus HS. Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer’s Disease? A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2018; 64(2): 657668. DOI: 10.3233/JAD-180288
  41. Vitali C, Wellington CL, Calabresi L. HDL and cholesterol handling in the brain. Cardiovascular Research. 2013; 103: 405413. DOI: 10.1093/cvr/cvu148
  42. Zhao E, Lowres N, Woolaston A, et al. Prevalence and patterns of cognitive impairment in acute coronary syndrome patients: A systematic review. Eur J Prev Cardiol. 2019; 13. DOI: 10.1177/2047487319878945
  43. Kirchhof P, Benussi S, Kotecha D, et al. Wytyczne ESC dotyczące leczenia migotania przedsionków w 2016 roku, opracowane we współpracy z EACTS. Kardiol Pol. 2016; 74: 13591469. DOI: 10.5603/KP.2016.0172
  44. Chu CS, Tseng PT, Stubbs B, et al. Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis. Sci Rep. 2018; 8(1): 5804. DOI: 10.1038/s41598-018-24248-8
DOI: https://doi.org/10.5334/gh.934 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 12, 2020
Accepted on: Jul 26, 2021
Published on: Aug 4, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Dominika Kasprzak, Janusz Rzeźniczak, Teresa Ganowicz, Tomasz Łuczak, Marek Słomczyński, Jarosław Hiczkiewicz, Paweł Burchardt, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.